Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. [electronic resource]
Producer: 20030321Description: 329-36 p. digitalISSN:- 0007-1048
- Aged
- Aged, 80 and over
- Antigens, CD34
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bone Marrow Cells -- drug effects
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Enzyme Activation
- Granulocyte Colony-Stimulating Factor -- pharmacology
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cells -- drug effects
- Humans
- Lymphoma -- drug therapy
- Middle Aged
- Prednisone -- administration & dosage
- Protein Kinase C -- genetics
- Protein Kinase C-alpha
- RNA -- analysis
- Telomerase -- genetics
- Telomere -- genetics
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.